Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

METTL13 Promotes Pre-Leukemic Transformation and the Development of Pediatric Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

SESabina EnlundCLChae-eun LimIHIsabella Hoang

Discussion

Loading...

Member takes

Overview

This research reveals that mettl13 significantly influences oncogenic development in pediatric T-ALL, suggesting a critical regulatory link with adenosine deaminase.

Key Points

  • Loss of mettl13 inhibits proliferation and survival in pediatric t-cell acute lymphoblastic leukemia, indicating its oncogenic potential.
  • METTL13 is uniquely upregulated by adenosine deaminase, while other METTL genes are downregulated in hematopoietic stem cells.
  • Knockdown of mettl13 altered gene expression involved in oncogenic development, showcasing its role in malignant transformation.
  • Functional studies confirm mettl13's necessity for T-ALL cell proliferation and survival both in vitro and in vivo.

Cite This Study

Enlund et al. (2025) studied this question.

synapsesocial.com/papers/68c2443bb210217d647aa1a5https://doi.org/10.1101/2025.08.29.673071
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting METTL3 disrupts oncogenic transcriptional programs and activates immune and apoptotic pathways in Acute Myeloid Leukemia2025
  2. 2Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia2025 · 1 citations
  3. 3METTL3: A dual regulator of oral tissue regeneration and malignancy with therapeutic implications for stem cell therapy and chemoresistance2025 · 1 citations
  4. 4The role of METTL14 in the progression of chronic myeloid leukemia2025 · 4 citations
  5. 5Targeting O-GlcNAcylated METTL3 impedes MDS/AML progression via diminishing SRSF1 m6A modification2025 · 1 citations